(Q48693125)

14 February 2018

title

PET network abnormalities and cognitive decline in patients with mild cognitive impairment. (English)

1 reference

14 February 2018

mild cognitive impairment

main subject

1 reference

10

1 reference

14 February 2018

Christian Habeck

2

Christian G Habeck

1 reference

14 February 2018

Nikolaos Scarmeas

4

Nikolaos Scarmeas

1 reference

14 February 2018

James R. Moeller

6

James R Moeller

1 reference

14 February 2018

Gregory H Pelton

5

Gregory H Pelton

1 reference

14 February 2018

Matthias H Tabert

3

Matthias H Tabert

1 reference

14 February 2018

Ronald L Van Heertum

9

Ronald L Van Heertum

1 reference

14 February 2018

Davangere Devanand

1

Davangere P Devanand

1 reference

14 February 2018

author name string

Brett D Mensh

7

1 reference

14 February 2018

Tyler Tarabula

8

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 2006

1 reference

14 February 2018

published in

Neuropsychopharmacology

1 reference

14 February 2018

volume

31

1 reference

14 February 2018

issue

6

1 reference

14 February 2018

page(s)

1327-1334

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300942

exact match

0 references

cites work

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Voxel-based mapping of brain hypometabolism in permanent amnesia with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

MRI and CSF studies in the early diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Functional brain networks in DYT1 dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Functional and effective connectivity in neuroimaging: A synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Network analysis of brain cognitive function using metabolic and blood flow data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Neuropsychological detection and characterization of preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Added Clinical Benefit of Incorporating 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Different brain networks mediate task performance in normal aging and AD: defining compensation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Metabolic changes following subthalamotomy for advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Functional deficits in patients with mild cognitive impairment: prediction of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300942

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1300942

1 reference

14 February 2018

PubMed ID

16292330

1 reference

14 February 2018